Diabetes & Endocrinology
406 - 420 of
1027 Results
Sort Results:
Article:
More payers are trying to rein in the use of antipsychotics in patients WITHOUT psychotic disorders
December 2013
Article:
More payers will recognize the value of pharmacists in improving the quality of patient care
November 2013
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013